Protocol ML39356: AN OPEN-LABEL, MULTICENTER, EXPANDED A

Project: Research project

Project Details

Description

Protocol ML39356: AN OPEN-LABEL, MULTICENTER, EXPANDED ACCESS PROGRAM FOR EMICIZUMAB IN PATIENTS WITH HEMOPHILIA A WITH INHIBITORS
StatusActive
Effective start/end date3/1/1712/31/20

Funding

  • Genentech Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.